{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:39:45Z","timestamp":1793277585691,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ekir.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T02:22:33Z","timestamp":1637893353000},"page":"210-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-3761","authenticated-orcid":false,"given":"Elisabeth L.","family":"Metry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander F.","family":"Garrelfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel","family":"Peters-Sengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Anne","family":"Hulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Acquaviva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Collard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-2915","authenticated-orcid":false,"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Mandrile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir H.","family":"Moochhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel J.S.","family":"Oosterveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Prikhodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap W.","family":"Groothoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2021.11.006_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria [published correction appears in N Engl J Med. 2013;369:2168]","volume":"369","author":"Cochat","year":"2013","journal-title":"N\u00a0Engl\u00a0J Med"},{"key":"10.1016\/j.ekir.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2014.222","article-title":"Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type","volume":"86","author":"Mandrile","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.2013.741587","article-title":"Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions","volume":"22","author":"Beck","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ekir.2021.11.006_bib5","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00467-021-05002-1","article-title":"Long-term complications of systemic oxalosis in children\u2014a retrospective single-center cohort study","volume":"36","author":"Ben-Shalom","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MOT.0b013e32833e35f5","article-title":"Primary hyperoxaluria type 1: strategy for organ transplantation","volume":"15","author":"Cochat","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.11.006_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","article-title":"Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment","volume":"27","author":"Cochat","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2215\/CJN.13821119","article-title":"End points for\u00a0clinical trials in primary hyperoxaluria","volume":"15","author":"Milliner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1399-3046.2005.00362.x","article-title":"Concurrent or sequential liver and kidney transplantation in children with primary hyperoxaluria type 1?","volume":"9","author":"Kemper","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib11","doi-asserted-by":"crossref","first-page":"e13457","DOI":"10.1111\/petr.13457","article-title":"Are two operations better than one? The debate over combined versus sequential liver-kidney transplantation from a single live donor in the treatment of primary hyperoxaluria 1","volume":"23","author":"Pham","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/petr.12595","article-title":"Combined liver and kidney transplantation and kidney after liver transplantation in children: indication, postoperative outcome, and long-term results","volume":"19","author":"B\u00fcscher","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.6002\/ect.2019.0150","article-title":"Liver transplant for primary hyperoxaluria type 1: results of sequential, combined liver and kidney, and preemptive liver transplant","volume":"19","author":"Horoub","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12876-020-01349-1","article-title":"Outcomes of liver-kidney transplantation in patients with primary hyperoxaluria: an analysis of the scientific registry of transplant recipients database","volume":"20","author":"Xiang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ekir.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ki.2009.435","article-title":"Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome","volume":"77","author":"Harambat","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ki.2009.471","article-title":"Evidence of true genotype-phenotype correlation in primary hyperoxaluria type 1","volume":"77","author":"Hoppe","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 Annual Report of the European Liver Transplant Registry (ELTR)\u201450-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00467-003-1234-x","article-title":"A\u00a0United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria","volume":"18","author":"Hoppe","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrneph.2015.54","article-title":"Primary disease recurrence\u2014effects on paediatric renal transplantation outcomes","volume":"11","author":"Bacchetta","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/ajt.12706","article-title":"Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant","volume":"14","author":"Lorenz","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1523-1755.2004.00796.x","article-title":"Clinical implications of mutation analysis in primary hyperoxaluria type 1","volume":"66","author":"van Woerden","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.11.006_bib23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbadis.2013.04.010","article-title":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","volume":"1832","author":"Fargue","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2021.11.006_bib24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/lt.24009","article-title":"Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience","volume":"20","author":"Compagnon","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ekir.2021.11.006_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2215\/CJN.07430711","article-title":"Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy","volume":"7","author":"Harambat","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib26","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-021-05043-6","article-title":"Transplantation outcomes in patients with primary hyperoxaluria: a systematic review","volume":"36","author":"Metry","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13406","article-title":"The experience of combined and sequential liver and kidney transplantation from a single living donor in patients with primary hyperoxaluria type 1","volume":"23","author":"Ozer","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00467-016-3324-6","article-title":"Pediatric combined liver-kidney transplantation: a single-center experience of 18 cases","volume":"31","author":"Duclaux-Loras","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.24167","article-title":"Preserving double equipoise in living donor liver-kidney transplantation for primary hyperoxaluria type 1","volume":"21","author":"Narasimhan","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ekir.2021.11.006_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/lt.23642","article-title":"Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1","volume":"19","author":"Mor","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ekir.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/petr.12376","article-title":"Two-step transplantation for primary hyperoxaluria: a winning strategy to prevent progression of systemic oxalosis in early onset renal insufficiency cases","volume":"19","author":"Sasaki","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2021.11.006_bib32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/TP.0b013e3181a27939","article-title":"Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth","volume":"87","author":"Brinkert","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00240-020-01197-4","article-title":"Plasma oxalate: comparison of methodologies","volume":"48","author":"Stokes","year":"2020","journal-title":"Urolithiasis"},{"key":"10.1016\/j.ekir.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00467-006-0124-4","article-title":"Primary hyperoxaluria type 1: still challenging!","volume":"21","author":"Cochat","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06820613","article-title":"Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ekir.2020.04.004","article-title":"Pyridoxine responsiveness in a type 1 primary hyperoxaluria patient with a rare (atypical) AGXT gene mutation","volume":"5","author":"Singh","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2021.11.006_bib37","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/acs.analchem.9b03670","article-title":"Development and validation of a new gas chromatography-tandem mass spectrometry method for the measurement of enrichment of glyoxylate metabolism analytes in hyperoxaluria patients using a stable isotope procedure","volume":"92","author":"van Harskamp","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.ekir.2021.11.006_bib39","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ekir.2020.09.022","article-title":"Transplantation for primary hyperoxaluria type 1: designing new strategies in the era of promising therapeutic perspectives","volume":"5","author":"Devresse","year":"2020","journal-title":"Kidney Int Rep"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921015126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921015126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:39:38Z","timestamp":1762832378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921015126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2468024921015126"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2021.11.006","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.12.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}